Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
83.50    -0.50 (-0.60%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £12.11m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Acquisition

6 Feb 2007 07:00

Adventis Group PLC06 February 2007 For release at 07.00 Feb 6th 2007 ADVENTIS GROUP PLC ACQUISITION OF LEAPFROG MEDICAL COMMUNICATIONS LTD Adventis Group plc ( "Adventis" or the "Company", ticker ATG), the specialistmultimedia and marketing group, is pleased to announce that it has acquiredLeapFrog Medical Communications Limited ("LeapFrog"), a leading medicaleducation company, for a total maximum consideration of £2.65 million. The total consideration will be satisfied by the payment of initialconsideration of £1.306 million, payable as to £0.874 million in cash and £0.432million by the issue of 975,169 new ordinary shares in Adventis ("New OrdinaryShares"), and by deferred consideration of £0.72 million payable in tranches of£0.24 million on each of the first, second and third anniversaries of theacquisition. Each deferred consideration tranche will be satisfied as to 60 percent in cash and as to 40 per cent payable in new ordinary shares in Adventis.There is further deferred consideration payable of up to £0.624 million, basedon the achievement of certain profit growth related criteria over the followingthree years to be satisfied annually according to performance as to 50 per centin cash and 50 per cent payable in new ordinary shares in Adventis. LeapFrog, whose clients include, GSK, Pfizer, MSD, Roche and Novartis, wasestablished in 2001. It provides a range of medical education programmes to thehealthcare industry, promotional aids for sales representatives and alsoinitiates PR campaigns aimed at healthcare professionals and consumers forimproving clients' product brand awareness. For the year ended 30 November 2006,LeapFrog reported audited turnover of approximately £1.57 million and pre-taxprofit of approximately £0.39 million. Net assets at that date amounted toapproximately £0.25 million. Tim Schofield and Gail Rowe, LeapFrog's principaldirectors, will remain with the company following the acquisition. The acquisition will create one of the industry's top three pharmaceuticalindustry service providers, becoming part of an enlarged Healthcare servicesdivision embracing Affiniti Advertising, acquired in 2005, and RoundhouseHealthAd, acquired in 2006. The addition of LeapFrog to Affiniti and Roundhouse creates a formidable,award-winning team in the Adventis Healthcare division, with over 50 employeesworking in centralised premises in the Thames Valley. The enlarged Healthcareservices operations, whose other clients include Boehringer Ingelheim, Allergan,Baxter and Merck Serono, will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets service. Application has been made for the admission to AIM of the New Ordinary Shares,which will rank pari passu with the Company's existing issued ordinary shares,and dealings are expected to commence on 9th February 2007. Charles Phillpot, CEO, Adventis Group, said: "We will now be one of the fewcompanies in the industry to offer a full service marketing capability and theability to handle larger and more complex campaigns for clients. We are nowamong the top three players in two of our three chosen market sectors." Tim Schofield and Gail Rowe said: "We see joining forces with the two topcreative agencies in our industry as a unique way of adding value to ourclients. Being able to address their various needs within one group will be atremendous bonus for us all." ENDS Enquiries: Adventis Group Plc Charles Phillpot, CEO 020 7034 4750 Peter Linnell, Finance Director & Company Secretary 020 7034 4795 Adventis Financial PR Chris Steele 020 7034 4759 Peter Binns 020 7034 4760 Editor's Note: Adventis Group plc, provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employs145 staff in London and the southeast. Adventis has two other divisions focusing on providing a range of services tothe property and financial sectors. Adventis Group was admitted to AIM in 2004,mainly operating as a media and marketing services provider to the propertysector. LeapFrog becomes the group's ninth operating company. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Sep 20107:00 amRNSInterim Results - half year ended 30 June 2010
18th Aug 20107:00 amRNSTrading Update
13th Aug 201012:25 pmRNSDirector/PDMR Shareholding
19th May 20104:01 pmRNSResult of AGM
19th May 20107:00 amRNSAGM Statement
5th May 201010:55 amRNSAnnual Report Published
30th Apr 20107:00 amRNSSettlement of Litigation
29th Apr 20101:30 pmRNSre RNS announcement
29th Apr 20107:00 amRNSSettlement of Litigation
29th Mar 20104:44 pmRNSDirectors' Dealings and Options Exercise
24th Mar 20107:00 amRNSFinal Results
2nd Feb 20107:00 amRNSAcquisition
29th Jan 20107:00 amRNSTrading Statement
16th Dec 200912:05 pmRNSHolding(s) in Company
19th Nov 20094:42 pmRNSHolding(s) in Company
12th Nov 20094:14 pmRNSHolding(s) in Company
12th Nov 20092:43 pmRNSHolding(s) in Company
11th Nov 20097:00 amRNSDirector/PDMR Shareholding
10th Nov 20092:23 pmRNSDirector/PDMR Shareholding
5th Nov 20097:00 amRNSPlacing
30th Sep 20097:00 amRNSInterim results
30th Jul 20097:00 amRNSTrading Update
3rd Jul 20095:35 pmRNSPayments of deferred and earn-out consideration
1st Jul 20094:48 pmRNSGrant of Share Options
3rd Jun 200912:53 pmRNSResult of AGM
3rd Jun 20097:00 amRNSAGM Statement
11th May 20095:04 pmRNSAnnual Report & Notice of AGM
15th Apr 20091:24 pmRNSHolding(s) in Company
15th Apr 200910:10 amRNSFinal Dividend
15th Apr 20097:00 amRNSFinal Results
12th Feb 20093:47 pmRNSDirector/PDMR Shareholding
29th Jan 20097:00 amRNSTrading Statement
21st Jan 20097:00 amRNSDirectorate Change
16th Jan 20093:09 pmRNSDirector/PDMR Shareholding
15th Dec 20084:01 pmRNSDirector/PDMR Shareholding
9th Dec 200812:32 pmRNSHolding(s) in Company
9th Dec 20089:34 amRNSDirector/PDMR Shareholding
8th Dec 20081:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20087:00 amRNSTrading Statement
20th Nov 20087:00 amRNSDirectorate Change
27th Oct 20083:12 pmRNSTransaction in Own Shares
10th Oct 20084:45 pmRNSTransaction in Own Shares
2nd Oct 200811:01 amRNSTransaction in Own Shares
30th Sep 20087:00 amRNSInterim Results
14th Aug 20085:09 pmRNSHolding(s) in Company
30th Jul 20087:00 amRNSTrading Statement
16th Jul 20084:56 pmRNSTransaction in Own Shares
15th Jul 20082:47 pmRNSTransaction in Own Shares
15th Jul 20088:48 amRNSTransaction in Own Shares
11th Jul 20084:36 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.